The abstract is read at the publisher; the summary is JClub's.
Weekly well-day capillary ketone testing is the lowest frequency that maintained similar 1-month DKA prediction accuracy in type 1 diabetes, using EASE-2/EASE-3 data (AUC 0.719 vs 0.711).
- Why it matters: Even with clinical risk factors, the minimum monitoring needed to preserve near-term DKA risk prediction accuracy is unclear, limiting practical implementation.
- What they did: Regression and gradient-boosted tree models simulated capillary ketone testing frequencies over a 1-month window in the EASE-2/EASE-3 repository (n = 1,410).
- The result: Compared with baseline twice-weekly testing, once-weekly testing showed no significant loss in accuracy for maximum ketone (AUC 0.692 vs 0.678; P = 0.19) or GBT models (0.719 vs 0.711; P = 0.38), suggesting weekly monitoring may stratify baseline DKA risk while reducing burden.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.